223 related articles for article (PubMed ID: 22558228)
1. Dosimetric selection for helical tomotherapy based stereotactic ablative radiotherapy for early-stage non-small cell lung cancer or lung metastases.
Chi A; Liao Z; Nguyen NP; Xu J; Welsh JS; Jang SY; Howe C; Komaki R
PLoS One; 2012; 7(4):e35809. PubMed ID: 22558228
[TBL] [Abstract][Full Text] [Related]
2. Feasibility of helical tomotherapy in stereotactic body radiation therapy for centrally located early stage non‒small-cell lung cancer or lung metastases.
Chi A; Jang SY; Welsh JS; Nguyen NP; Ong E; Gobar L; Komaki R
Int J Radiat Oncol Biol Phys; 2011 Nov; 81(3):856-62. PubMed ID: 21255942
[TBL] [Abstract][Full Text] [Related]
3. Critical structure sparing in stereotactic ablative radiotherapy for central lung lesions: helical tomotherapy vs. volumetric modulated arc therapy.
Chi A; Ma P; Fu G; Hobbs G; Welsh JS; Nguyen NP; Jang SY; Dai J; Jin J; Komaki R
PLoS One; 2013; 8(4):e59729. PubMed ID: 23577071
[TBL] [Abstract][Full Text] [Related]
4. Technical Note: Dosimetric evaluation of Monte Carlo algorithm in iPlan for stereotactic ablative body radiotherapy (SABR) for lung cancer patients using RTOG 0813 parameters.
Pokhrel D; Badkul R; Jiang H; Kumar P; Wang F
J Appl Clin Med Phys; 2015 Jan; 16(1):5058. PubMed ID: 25679161
[TBL] [Abstract][Full Text] [Related]
5. Assessment of Monte Carlo algorithm for compliance with RTOG 0915 dosimetric criteria in peripheral lung cancer patients treated with stereotactic body radiotherapy.
Pokhrel D; Sood S; Badkul R; Jiang H; McClinton C; Lominska C; Kumar P; Wang F
J Appl Clin Med Phys; 2016 May; 17(3):277-293. PubMed ID: 27167284
[TBL] [Abstract][Full Text] [Related]
6. Stereotactic ablative radiotherapy for ultra-central lung tumors: prioritize target coverage or organs at risk?
Murrell DH; Laba JM; Erickson A; Millman B; Palma DA; Louie AV
Radiat Oncol; 2018 Apr; 13(1):57. PubMed ID: 29606150
[TBL] [Abstract][Full Text] [Related]
7. Analysis of dose distribution and risk of pneumonitis in stereotactic body radiation therapy for centrally located lung tumors: a comparison of robotic radiosurgery, helical tomotherapy and volumetric modulated arc therapy.
Kannarunimit D; Descovich M; Garcia A; Chen J; Weinberg V; Mcguinness C; Pinnaduwage D; Murnane J; Gottschalk AR; Yom SS
Technol Cancer Res Treat; 2015 Feb; 14(1):49-60. PubMed ID: 24325136
[TBL] [Abstract][Full Text] [Related]
8. Planning evaluation of radiotherapy for complex lung cancer cases using helical tomotherapy.
Kron T; Grigorov G; Yu E; Yartsev S; Chen JZ; Wong E; Rodrigues G; Trenka K; Coad T; Bauman G; Van Dyk J
Phys Med Biol; 2004 Aug; 49(16):3675-90. PubMed ID: 15446797
[TBL] [Abstract][Full Text] [Related]
9. Comprehensive dosimetric planning comparison for early-stage, non-small cell lung cancer with SABR: fixed-beam IMRT versus VMAT versus TomoTherapy.
Xhaferllari I; El-Sherif O; Gaede S
J Appl Clin Med Phys; 2016 Sep; 17(5):329-340. PubMed ID: 27685129
[TBL] [Abstract][Full Text] [Related]
10. Dose as a function of lung volume and planned treatment volume in helical tomotherapy intensity-modulated radiation therapy-based stereotactic body radiation therapy for small lung tumors.
Baisden JM; Romney DA; Reish AG; Cai J; Sheng K; Jones DR; Benedict SH; Read PW; Larner JM
Int J Radiat Oncol Biol Phys; 2007 Jul; 68(4):1229-37. PubMed ID: 17513066
[TBL] [Abstract][Full Text] [Related]
11. Proton stereotactic body radiation therapy for clinically challenging cases of centrally and superiorly located stage I non-small-cell lung cancer.
Register SP; Zhang X; Mohan R; Chang JY
Int J Radiat Oncol Biol Phys; 2011 Jul; 80(4):1015-22. PubMed ID: 20615629
[TBL] [Abstract][Full Text] [Related]
12. Superiority of conventional intensity-modulated radiotherapy over helical tomotherapy in locally advanced non-small cell lung cancer. A comparative plan analysis.
Song C; Pyo H; Kim J; Lim YK; Kim WC; Kim HJ; Kim DW; Cho KH
Strahlenther Onkol; 2012 Oct; 188(10):901-9. PubMed ID: 22895625
[TBL] [Abstract][Full Text] [Related]
13. A potential to reduce pulmonary toxicity: the use of perfusion SPECT with IMRT for functional lung avoidance in radiotherapy of non-small cell lung cancer.
Lavrenkov K; Christian JA; Partridge M; Niotsikou E; Cook G; Parker M; Bedford JL; Brada M
Radiother Oncol; 2007 May; 83(2):156-62. PubMed ID: 17493699
[TBL] [Abstract][Full Text] [Related]
14. Development and clinical validation of a robust knowledge-based planning model for stereotactic body radiotherapy treatment of centrally located lung tumors.
Visak J; McGarry RC; Randall ME; Pokhrel D
J Appl Clin Med Phys; 2021 Jan; 22(1):146-155. PubMed ID: 33285034
[TBL] [Abstract][Full Text] [Related]
15. Helical tomotherapy to LINAC plan conversion utilizing RayStation Fallback planning.
Zhang X; Penagaricano J; Narayanasamy G; Corry P; Liu T; Sanjay M; Paudel N; Morrill S
J Appl Clin Med Phys; 2017 Jan; 18(1):178-185. PubMed ID: 28291935
[TBL] [Abstract][Full Text] [Related]
16. Approach and assessment of automated stereotactic radiotherapy planning for early stage non-small-cell lung cancer.
Bai X; Shan G; Chen M; Wang B
Biomed Eng Online; 2019 Oct; 18(1):101. PubMed ID: 31619263
[TBL] [Abstract][Full Text] [Related]
17. Can reducing planning safety margins broaden the inclusion criteria for lung stereotactic ablative body radiotherapy?
Ghandourh W; Batumalai V; Boxer M; Holloway L
J Med Radiat Sci; 2021 Sep; 68(3):298-309. PubMed ID: 33934559
[TBL] [Abstract][Full Text] [Related]
18. Dosimetric comparison of stereotactic body radiotherapy using 4D CT and multiphase CT images for treatment planning of lung cancer: evaluation of the impact on daily dose coverage.
Wang L; Hayes S; Paskalev K; Jin L; Buyyounouski MK; Ma CC; Feigenberg S
Radiother Oncol; 2009 Jun; 91(3):314-24. PubMed ID: 19111362
[TBL] [Abstract][Full Text] [Related]
19. Helical tomotherapy of nasopharyngeal carcinoma-any advantages over conventional intensity-modulated radiotherapy?
Wu WC; Mui WL; Fung WK
Med Dosim; 2010; 35(2):122-7. PubMed ID: 19931024
[TBL] [Abstract][Full Text] [Related]
20. Planning Target Volume D95 and Mean Dose Should Be Considered for Optimal Local Control for Stereotactic Ablative Radiation Therapy.
Zhao L; Zhou S; Balter P; Shen C; Gomez DR; Welsh JD; Lin SH; Chang JY
Int J Radiat Oncol Biol Phys; 2016 Jul; 95(4):1226-35. PubMed ID: 27209498
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
